Get started
Author

Isao Hidaka

Observed names: Hidaka Isao, Hidaka, I., Hidaka, Isao, I Hidaka, I. Hidaka, Isao HIDAKA, 勲 日高, 日高勲
ORCID: 0009-0008-8726-7635
Observed ORCIDs: 0009-0008-8726-7635, 0000-0003-3693-4270
OpenAlex ID: A5041104423
Hepatitis C Virus–Induced Reactive Oxygen Species Raise Hepatic Iron Level in Mice by Reducing Hepcidin Transcription
2007 · Sohji Nishina, Keisuke Hino, et al. · Gastroenterology · 264
CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis
2017 · Michiko Itoh, Takayoshi Suganami, et al. · JCI Insight · 98
Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
2016 · Issei Saeki, Naoki Yamamoto, et al. · World Journal of Gastroenterology · 61
PDF
Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma
2020 · Yurika Kotoh, Yutaka Suehiro, et al. · Hepatology Communications · 57
PDF
Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH
2021 · Yohei Kanamori, Miyako Tanaka, et al. · iScience · 54
PDF
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
2023 · Michiko Itoh, Atsushi Tamura, et al. · The Journal of Experimental Medicine · 53
PDF
Increased expression and phosphorylation of liver glutamine synthetase in well‐differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus
2006 · Yasuhiro Kuramitsu, Toshio Harada, et al. · Electrophoresis · 49
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment
2020 · Issei Saeki, Takahiro Yamasaki, et al. · Cancers · 48
PDF
Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma
2016 · Kübra Altinel, Kosuke Hashimoto, et al. · Journal of Virology · 44
PDF
Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species
2006 · Yuichi Hara, Keisuke Hino, et al. · Journal of Gastroenterology · 44
A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice
2011 · Masaaki Korenaga, Isao Hidaka, et al. · Liver International · 40
Status and Prospects of Liver Cirrhosis Treatment by Using Bone Marrow-Derived Cells and Mesenchymal Cells
2014 · Shuji Terai, Taro Takami, et al. · Tissue Engineering Part B Reviews · 36
In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis
2005 · Akira Kitase, Keisuke Hino, et al. · Journal of Gastroenterology · 36
No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma
2018 · Issei Saeki, Takahiro Yamasaki, et al. · Liver Cancer · 35
PDF
Stronger Neo‐Minophagen C™, a glycyrrhizin‐containing preparation, protects liver against carbon tetrachloride‐induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein
2007 · Isao Hidaka, Keisuke Hino, et al. · Liver International · 34
Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon‐occluded retrograde transvenous obliteration
2018 · Tsuyoshi Ishikawa, Ryo Sasaki, et al. · Hepatology Research · 33
Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice
2010 · Sohji Nishina, Masaaki Korenaga, et al. · Liver International · 33
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy
2012 · Shuji Terai, Haruko Tanimoto, et al. · Journal of Gastroenterology · 30
A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy
2015 · Issei Saeki, Takahiro Yamasaki, et al. · PLoS ONE · 28
Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication
2008 · Mie Ando, Masaaki Korenaga, et al. · Liver International · 27
PDF
Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
2018 · Issei Saeki, Takahiro Yamasaki, et al. · World Journal of Hepatology · 26
PDF
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
2020 · Masanori Atsukawa, Akihito Tsubota, et al. · Infectious Diseases and Therapy · 24
PDF
A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification
2019 · Tsuyoshi Ishikawa, Ryo Sasaki, et al. · PLoS ONE · 24
PDF
Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion
2018 · Tsuyoshi Ishikawa, Ryo Sasaki, et al. · Journal of Gastroenterology and Hepatology · 23
PDF
Clinical Characteristics of Patients who Developed Hepatocellular Carcinoma after Hepatitis C Virus Eradication with Interferon Therapy: Current Status in Japan
2013 · Akira Sato, Michio Sata, et al. · Internal Medicine · 22
PDF
Works count: 79
Citation count: 1,520
H-index: 23
I10-index: 36
Year
Topic
Type